Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate

Daniela Kiepe1, Tim Ulinski, David R Powell

  • 1Division of Pediatric Nephrology, University Children's Hospital, Heidelberg, Germany.

Kidney International
|October 10, 2002
PubMed

Insights

Insulin-like growth factor binding proteins (IGFBPs) impact growth in children with chronic renal failure. IGFBP-1, -2, and -6 inhibit chondrocyte proliferation, while IGFBP-3

Area of Science:

  • Endocrinology
  • Pediatric Nephrology
  • Cell Biology

Background:

  • Children with chronic renal failure (CRF) often experience impaired longitudinal growth.
  • Excessive insulin-like growth factor binding proteins (IGFBPs) may interfere with insulin-like growth factor (IGF) signaling, impacting growth.
  • Different IGFBPs may have contrasting effects on longitudinal growth.

Purpose of the Study:

  • To investigate the biological effects of IGFBP-1, -2, -3, and -6 on growth plate chondrocytes.
  • To understand the role of IGFBPs in modulating longitudinal growth in pediatric CRF.

Main Methods:

  • Primary rat growth plate chondrocytes were cultured.
  • Proliferation was assessed using colony formation and [3H]thymidine assays.
  • IGFBP binding to chondrocytes and IGF-I binding were evaluated.

Main Results:

  • IGFBP-1, IGFBP-2, and IGFBP-6 inhibited IGF-stimulated DNA synthesis and proliferation.
  • IGFBP-3 exhibited complex effects: inhibiting proliferation independently and dependently on IGF, but enhancing IGF-I responsiveness under preincubation conditions.
  • IGFBP-3 facilitates IGF-I binding to the cell membrane.

Conclusions:

  • IGFBP-1, IGFBP-2, and IGFBP-6 act as growth inhibitors on chondrocyte proliferation.
  • IGFBP-3 can either inhibit or enhance chondrocyte proliferation and IGF responsiveness, depending on its temporal relationship with IGF exposure.
  • Findings highlight the differential roles of IGFBPs in regulating chondrocyte function and longitudinal growth.
Abstract